(Q43762657)

26 November 2017

title

Studies on dopaminergic and GABAergic markers in striatum reveals a decrease in the dopamine transporter in schizophrenia (English)

1 reference

26 November 2017

0 references

0 references

1 reference

1

1 reference

26 November 2017

T Hussain

2

1 reference

26 November 2017

language of work or name

English

0 references

publication date

1 October 2001

1 reference

26 November 2017

published in

Schizophrenia Research

1 reference

26 November 2017

volume

52

1 reference

26 November 2017

issue

1-2

1 reference

26 November 2017

page(s)

107-114

1 reference

Effects of antipsychotic drugs on dopamine and serotonin contents and metabolites, dopamine and serotonin transporters, and serotonin1A receptors

26 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2800%2900096-7

7 January 2021

Nitric oxide synthase-containing neurons in the human hypothalamus: reduced number of immunoreactive cells in the paraventricular nucleus of depressive patients and schizophrenics

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2800%2900096-7

7 January 2021

Schizophrenia is associated with elevated amphetamine-induced synaptic dopamine concentrations: evidence from a novel positron emission tomography method

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2800%2900096-7

7 January 2021

Neurotransmitter aberrations in schizophrenia: new perspectives and therapeutic implications

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2800%2900096-7

7 January 2021

Dopamine receptors in human brain: autoradiographic distribution of D1 sites

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2800%2900096-7

7 January 2021

[3H] GBR 12935 binding to the dopamine uptake site in post-mortem brain tissue in schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2800%2900096-7

7 January 2021

Changes in serotonin2A and GABA(A) receptors in schizophrenia: studies on the human dorsolateral prefrontal cortex

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2800%2900096-7

7 January 2021

Application of [3H]L-N(G)-nitro-arginine labelling to measure cerebellar nitric oxide synthase in patients with schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2800%2900096-7

7 January 2021

D2 dopamine receptors in neuroleptic-naive schizophrenic patients. A positron emission tomography study with [11C]raclopride

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2800%2900096-7

7 January 2021

Mesolimbic dopamine D3 receptors and use of antipsychotics in patients with schizophrenia. A postmortem study.

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2800%2900096-7

7 January 2021

[3H]muscimol binding sites increased in autopsied brains of chronic schizophrenics

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2800%2900096-7

7 January 2021

Brain sigma receptors labelled by [3H]nemonapride

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2800%2900096-7

7 January 2021

Autoradiographic distribution of D3-type dopamine receptors in human brain using [3H]7-hydroxy-N,N-di-n-propyl-2-aminotetralin

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2800%2900096-7

7 January 2021

Dopamine receptor subtype imbalance in schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2800%2900096-7

7 January 2021

Problem of diagnosis in postmortem brain studies of schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2800%2900096-7

7 January 2021

[3H]mazindol binding associated with neuronal dopamine uptake sites in corpus striatum membranes.

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2800%2900096-7

7 January 2021

Organization of dopamine D1 and D2 receptors in human striatum: receptor autoradiographic studies in Huntington's disease and schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2800%2900096-7

7 January 2021

Nitric oxide synthase (NOS) in schizophrenia: increases in cerebellar vermis.

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2800%2900096-7

7 January 2021

Tissue pH as an indicator of mRNA preservation in human post-mortem brain

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2800%2900096-7

7 January 2021

Quantitative autoradiography of dopamine-D1 receptors, D2 receptors, and dopamine uptake sites in postmortem striatal specimens from schizophrenic patients.

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2800%2900096-7

7 January 2021

Single photon emission computerized tomography imaging of amphetamine-induced dopamine release in drug-free schizophrenic subjects

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2800%2900096-7

7 January 2021

Dopamine receptors and schizophrenia: drug effect or illness?

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2800%2900096-7

7 January 2021

The estimated density of D2 striatal receptors in schizophrenia. A study with positron emission tomography and 76Br-bromolisuride.

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2800%2900096-7

7 January 2021

Biological studies in schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2800%2900096-7

7 January 2021

Distribution of putative D4 dopamine receptors in postmortem striatum from patients with schizophrenia.

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2800%2900096-7

7 January 2021

Frontal-striatal cognitive deficits in patients with chronic schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2800%2900096-7

7 January 2021

Dopamine uptake sites and dopamine receptors in Parkinson's disease and schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2800%2900096-7

7 January 2021

[3H]SCH 23390 labeled D1 dopamine receptors are unchanged in schizophrenia and Parkinson's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2800%2900096-7

7 January 2021

Brain dopamine transporter: gender differences and effect of chronic haloperidol.

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2800%2900096-7

7 January 2021

Presence of sigma and phencyclidine (PCP)-like receptors in membrane preparations of bovine adrenal medulla

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2800%2900096-7

7 January 2021

Effect of dopaminergic drugs on the in vivo binding of [3H]WIN 35,428 to central dopamine transporters.

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2800%2900096-7

7 January 2021

Human brain D1 and D2 dopamine receptors in schizophrenia, Alzheimer's, Parkinson's, and Huntington's diseases

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2800%2900096-7

7 January 2021

Dopamine D4 receptors elevated in schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2800%2900096-7

7 January 2021

An improved approach to prepare human brains for research

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2800%2900096-7

7 January 2021

10.1016/S0920-9964(00)00096-7

Identifiers

DOI

1 reference

26 November 2017

1 reference